首页> 外文期刊>Biological & pharmaceutical bulletin >Effects of Bak Foong Pill on Blood Coagulation and Platelet Aggregation
【24h】

Effects of Bak Foong Pill on Blood Coagulation and Platelet Aggregation

机译:白凤丸对凝血和血小板聚集的影响

获取原文
获取原文并翻译 | 示例
           

摘要

The effects of Bak Foong Pill (BFP, also known as Bai Feng Wan), a preparation of crude drugs in wide clinical use for treatment of gynecological disorders, on blood coagulation and platelet aggregation were investigated. The anticoagulant effect of BFP was evaluated by using thrombin time (TT), prothrombin time (PT), and activated partial thromboplastin time (APTT) assays. Results showed that BFP 70% ethanol extract (BFP-E-ext) significantly prolonged the TT in a dose-dependent manner with values of 17.6, 38.3, and 50.4 s at concentrations of 4.0, 6.0, and 12.0 mg/ml, respectively. Whereas, the BFP-E-ext did not show significant prolonging effect in PT and APTT assays. The results suggest that the anticoagulant effect of BFP is mediated by directly blocking thrombin, the key enzyme in the blood coagulation cascade. BFP-E-ext significantly inhibited platelet aggregation induced by collagen and adenosine diphosphate (ADP) with inhibition percentages of 74 and 52% at a concentration of 6.0 mg/ml, respectively, whereas, it exhibited a weak inhibitory activity on platelet aggregation induced by archidonic acid (AA). Comparing to BFP-E-ext, the effects of BFP aqueous extract (BFP-W-ext) on both anticoagulant and antiplatelet activities were significantly less potent. Moreover, the effects of the 26 ingredients of BFP on blood coagulation and platelet aggregation were separately evaluated with 19 ingredient herbs exhibiting anticoagulant effect and 10 exhibiting antiplatelet effect. The anticoagulant and antiplatelet effects of BFP were collectively demonstrated by in vivo assays showing prolonged bleeding times after BFP treatment for two weeks. The results of the present studies may provide explanations for beneficial effects of BFP on the circulation and indicate its potential use for cardiovascular diseases.
机译:研究了白凤丸(BFP,也称为白凤丸)(一种广泛用于妇科疾病的临床药物)对凝血和血小板聚集的影响。通过使用凝血酶时间(TT),凝血酶原时间(PT)和活化的部分凝血活酶时间(APTT)分析评估了BFP的抗凝作用。结果表明,在浓度为4.0、6.0和12.0 mg / ml的情况下,BFP 70%乙醇提取物(BFP-E-ext)以剂量依赖性方式显着延长TT值,分别为17.6、38.3和50.4 s。而BFP-E-ext在PT和APTT分析中未显示出明显的延长作用。结果表明,BFP的抗凝作用是通过直接阻断凝血酶(凝血级联中的关键酶)介导的。 BFP-E-ext显着抑制胶原蛋白和二磷酸腺苷(ADP)诱导的血小板凝集,在6.0 mg / ml的浓度下分别抑制率分别为74%和52%,而对由AFP诱导的血小板凝集表现出较弱的抑制活性。存档酸(AA)。与BFP-E-ext相比,BFP水提取物(BFP-W-ext)对抗凝和抗血小板活性的作用均显着减弱。此外,分别用19种具有抗凝作用的草药和10种具有抗血小板作用的草药分别评估了BFP的26种成分对凝血和血小板凝集的作用。通过体内试验共同证明了BFP的抗凝和抗血小板作用,显示BFP治疗两周后出血时间延长。本研究的结果可为BFP对循环的有益作用提供解释,并指出其在心血管疾病中的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号